Search Within

Andriy Derkach

Formats
  1. Meeting Abstract (104)
  2. Journal Article (56)
  3. Research Letter (11)
  4. Correspondence (3)
Groups
  1. Biostatistics Service (174)
  2. Epidemiology and Biostatistics (174)
  3. Population Sciences Research Program (174)
  4. Department of Medicine (160)
  5. Hematologic Malignancies, Division of (159)
  6. Center for Hematologic Malignancies (153)

More Groups

People
  1. Urvi Shah (80)
  2. Malin Hultcrantz (79)
  3. Alexander Lesokhin (78)
  4. Carlyn Rose Tan (71)
  5. Sham Mailankody (71)
  6. Hani Hassoun (70)

More People

Years
  1. 2025 (10)
  2. 2024 (47)
  3. 2023 (44)
  4. 2022 (35)
  5. 2021 (22)
  6. 2020 (16)
Publications
  1. Blood (75)
  2. Clinical Lymphoma, Myeloma and Leukemia (21)
  3. Journal of Clinical Oncology (14)
  4. Blood Advances (10)
  5. Leukemia and Lymphoma (6)
  6. Blood Cancer Journal (5)

More Publications

Publishers
  1. American Society of Hematology (85)
  2. Elsevier Inc. (24)
  3. American Society of Clinical Oncology (14)
  4. Nature Publishing Group (12)
  5. American Association for Cancer Research (8)
  6. Taylor & Francis Group (6)

More Publishers

Results (174)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Venetoclax-based combinations in AML and high-risk MDS prior to and following allogeneic hematopoietic cell transplant
    Journal Article

    Bewersdorf, J. P.; Derkach, A.; Gowda, L.; Menghrajani, K.; DeWolf, S.; Ruiz, J. D.; Ponce, D. M.; Shaffer, B. C.; Tamari, R.; Young, J. W.; more...
    Leukemia and Lymphoma (2021)

    Fulltext@MSK | Save
  • Serum antibody response in patients with philadelphia-chromosome positive or negative myeloproliferative neoplasms following vaccination with SARS-CoV-2 spike protein messenger RNA (mRNA) vaccines
    Research Letter

    Kozak, K. E.; Ouyang, L.; Derkach, A.; Sherman, A.; McCall, S. J.; Famulare, C.; Chervin, J.; Daley, R. J.; Morjaria, S.; Mauro, M. J.; more...
    Leukemia (2021)

    Fulltext@MSK | Save
  • Using mobile wearables to establish sleep bioprofiles in newly diagnosed multiple myeloma (MM) patients
    Meeting Abstract

    Hevroni, G.; Mastey, D.; Tavitian, E.; Derkach, A.; Salcedo, M.; Mailankody, S.; Hassoun, H.; Lesokhin, A. M.; Smith, E. L.; Hultcrantz, M.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Providing nutritional guidance for patients with plasma cell disorders - A missed opportunity for hematologists and oncologists?
    Meeting Abstract

    Sweeney, N.; Malik, M.; Jafri, M.; Derkach, A.; Chmielewski, C.; Adintori, P.; Mailankody, S.; Korde, N.; Tan, C.; Hassoun, H.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2021)

    Fulltext@MSK | Save
  • Sustained minimal residual disease negativity in multiple myeloma is impacted positively by stool butyrate and healthier plant forward diets
    Meeting Abstract

    Shah, U.; Derkach, A.; Adintori, P.; Cross, J.; Maclachlan, K.; Mailankody, S.; Korde, N.; Hultcrantz, M.; Hassoun, H.; Tan, C.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2021)

    Fulltext@MSK | Save
  • Clonal hematopoiesis is associated with risk of severe COVID-19
    Journal Article

    Bolton, K. L.; Koh, Y.; Foote, M. B.; Im, H.; Jee, J.; Sun, C. H.; Safonov, A.; Ptashkin, R.; Moon, J. H.; Lee, J. Y.; more...
    Nature Communications (2021)

    Fulltext@MSK | Save
  • Copy number signatures predict chromothripsis and clinical outcomes in newly diagnosed multiple myeloma
    Journal Article

    Maclachlan, K. H.; Rustad, E. H.; Derkach, A.; Zheng-Lin, B.; Yellapantula, V.; Diamond, B.; Hultcrantz, M.; Ziccheddu, B.; Boyle, E. M.; Blaney, P.; more...
    Nature Communications (2021)

    Fulltext@MSK | Save
  • Neutropenia in adult acute myeloid leukemia patients represents a powerful risk factor for COVID-19 related mortality
    Journal Article

    Stahl, M.; Narendra, V.; Jee, J.; Derkach, A.; Maloy, M.; Geyer, M. B.; Mato, A. R.; Roeker, L. E.; Tallman, M. S.; Shah, G. L.; more...
    Leukemia and Lymphoma (2021)

    Fulltext@MSK | Save
  • Safety and effectiveness of weekly carfilzomib, lenalidomide, dexamethasone, and daratumumab combination therapy for patients with newly diagnosed multiple myeloma the MANHATTAN nonrandomized clinical trial
    Journal Article

    Landgren, O.; Hultcrantz, M.; Diamond, B.; Lesokhin, A. M.; Mailankody, S.; Hassoun, H.; Tan, C.; Shah, U. A.; Lu, S. X.; Salcedo, M.; more...
    JAMA Oncology (2021)

    Fulltext@MSK | Save
  • Dynamics of minimal residual disease in patients with multiple myeloma on continuous lenalidomide maintenance: A single-arm, single-centre, phase 2 trial
    Journal Article

    Diamond, B.; Korde, N.; Lesokhin, A. M.; Smith, E. L.; Shah, U.; Mailankody, S.; Hultcrantz, M.; Hassoun, H.; Lu, S. X.; Tan, C.; more...
    The Lancet Haematology (2021)

    Fulltext@MSK | Save